SCHEMBL4207828

SCHEMBL4207828

CCOC(=O)C(CN1CCC(NC)CC1)c1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
GAA P10253 1/20 0.48
ALDH1A1 P00352 4/20 0.47
SLC6A2 P23975 3/20 0.44
SLC6A3 Q01959 3/20 0.44
SLC6A4 P31645 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
PAX8 Q06710 2/20 0.44
JAK2 O60674 1/20 0.44
MITF O75030 2/20 0.44
HTT P42858 1/20 0.44
RAB9A P51151 1/20 0.44
GFER P55789 1/20 0.44
ATM Q13315 1/20 0.44
LMNA P02545 1/20 0.44
HIF1A Q16665 1/20 0.44
TSHR P16473 1/20 0.43
OPRM1 P35372 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2552200 0.83 ALDH1A1 (0.62) KDM4EGAAALDH1A1SLC6A2SLC6A3
SCHEMBL2552921 0.81 ALDH1A1 (0.61) KDM4EGAAALDH1A1SLC6A2SLC6A3
SCHEMBL30771327 0.80 GAA (0.57) KDM4EGAAALDH1A1SMN1; SMN2PAX8
SCHEMBL10502713 0.79 GAA (0.52) KDM4EGAAALDH1A1SLC6A2SLC6A3
SCHEMBL2551775 0.79 SMN1; SMN2 (0.65) KDM4EGAAALDH1A1MEN1KMT2A
SCHEMBL15151008 0.78 SIGMAR1 (0.45) KDM4EGAAALDH1A1SLC6A2SLC6A3
SCHEMBL21807155 0.78 GAA (0.50) KDM4EGAAALDH1A1SLC6A2SLC6A3
SCHEMBL14327144 0.77 ALDH1A1 (0.58) KDM4EALDH1A1MEN1KMT2ARAB9A
SCHEMBL15630697 0.73 ALDH1A1 (0.70) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL12188412 0.73 NTSR1 (0.43) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7488738-B2 Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof ASUBIO PHARMA CO., LTD. (JP) 2009-02-10 US disclosed
US-6998401-B2 Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof SUNTORY LIMITED (JP) 2006-02-14 US disclosed
US-20050245574-A1 Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2005-11-03 US disclosed
EP-1045693-B1 AMINOPHENOXYACETIC ACID DERIVATIVES AS NEUROPROTECTANTS DAIICHI SUNTORY PHARMA CO LTD (JP) 2004-06-30 EP disclosed
US-20040063748-A1 Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof ASUBIO PHARMA CO., LTD. (JP) 2004-04-01 US disclosed
US-6559146-B1 Neuroprotective effects by inducing calbindin D28Kd, one of Ca2+-binding proteins SUNTORY LIMITED (JP) 2003-05-06 US disclosed
EP-1045693-A1 AMINOPHENOXYACETIC ACID DERIVATIVES AS NEUROPROTECTANTS SUNTORY LIMITED (JP) 2000-10-25 EP disclosed
WO-2000023076-A1 AMINOPHENOXYACETIC ACID DERIVATIVES AS NEUROPROTECTANTS SUNTORY LIMITED (JP) 2000-04-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245574-A1 Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof CAMK2A, CAMK2B, SLC1A2 KDM4E 1253/4885GAA 2706/4885ALDH1A1 1522/4885
US-20040063748-A1 Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof FABP7, SLC1A2, CAMK2A KDM4E 1506/4885GAA 2169/4885ALDH1A1 1079/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.